Participated · Series A · Feb 2026

Seasats develops autonomous surface vessels that can operate for weeks or months, tackling the “dull” but mission-critical tasks of persistent maritime surveillance, port security, and coastal patrol. Its flagship long-endurance craft has completed both trans-Pacific and trans-Atlantic crossings, while its interceptor platform has run continuous week-long operations, validating reliability and range. The company combines commercial manufacturing agility with defense-grade robustness to deliver cost-effective, scalable maritime autonomy. Demand is accelerating: Seasats has landed more than $100 million in U.S. government contracts, including awards from the U.S. Navy, U.S. Marine Corps, and the Department of War’s APFIT program. To date, the firm has raised over $40 million in venture funding. Fresh capital will expand production capacity, open new facilities, launch additional product lines, and grow the team to meet surging domestic and international interest. Headquartered in San Diego, Seasats positions itself as a key enabler of maritime domain awareness and risk reduction for both military and commercial customers.

Participated · Series B · Oct 2025

Ansa Biotechnologies is a DNA synthesis company based in Emeryville, CA that focuses on producing sequence-perfect clonal DNA and sequence-verified linear double-stranded DNA fragments. Its platform aims to give scientists rapid, accurate access to synthetic DNA for applications across healthcare, life sciences, and other industries. To reinforce reliability, the company recently launched the Ansa On-Time Guarantee, promising that any order not shipped in full and on time will be provided free of charge. It has also rolled out a new pricing framework targeting low-complexity DNA sequences to make routine orders more cost-effective. With its latest capital infusion, Ansa plans to expand U.S. manufacturing capacity, deepen customer-experience initiatives, and strengthen strategic partnerships while advancing its technology stack. Although no revenue or user figures were disclosed, the firm’s continued fundraising indicates growing market traction and operational scaling needs.

Participated · Series B · Apr 2024

OROS Labs builds Solarcore®, a polymer aerogel–based insulation material that the company says is the world’s lowest thermally conductive solid and is designed for durability and versatility across many product categories. Solarcore® targets applications from cold-weather apparel to structures, packaging, and aerospace/space thermal management, claiming benefits in heat retention, reduced weight, and improved transport and setup efficiencies. The company highlights dual-use demand and strategic partnerships with consumer footwear brands (Merrell, L.L. Bean) and the U.S. Department of Defense, including work to upgrade Army cold-weather tactical shelters. OROS emphasizes commercialization through expanded manufacturing, scaled product offerings, and continued research and development. The company has also recruited an experienced leadership and advisory team from industry and defense backgrounds to support growth.

Participated · Seed · Jan 2024

TARA Mind develops a clinician-guided, data-driven collaborative care platform to deliver ketamine-assisted therapy (KAT) and other emerging mental health treatments as an employer-covered benefit. The company focuses on individuals with treatment-resistant mental health disorders and aims to integrate personalized, evidence-based care into self-funded employer benefit plans. TARA Mind maintains a structured real-world evidence dataset to support outcomes and decision-making and emphasizes measurable ROI for employers via reduced medical costs, lower absenteeism, and improved productivity. The firm positions itself as a first mover in the employer benefit space for psychedelic-assisted therapies and seeks to expand affordable access nationwide. Founded in 2022 by Marcus Capone with involvement from Red Cell Partners (Grant Verstandig and Dr. Yisroel Brumer), TARA Mind is organized as a public benefit corporation and is scaling its provider network and employer partnerships. The company recently completed a seed financing round to support that expansion. TARA Mind, founded in 2022, is a Public Benefit Corporation emerging from stealth to expand safe, affordable, and effective access to psychedelic-assisted therapy (PAT). The company has built a network of vetted PAT providers across the US and abroad and is developing proprietary digital measurement-based care tools to ensure safety, optimize outcomes, and enable data-driven, value-based reimbursement. It has codified The TARA Mind Way™ and PTIM™, a clinician-guided framework of Preparation, Treatment, Integration, and Monitoring, to guarantee wraparound services and standardize care. TARA Mind is working with early-adopter employers to add its provider network as a supplemental benefit to existing health plans to reduce equity barriers and drive employer ROI. The company has convened medical advisors from institutions including Harvard, Stanford, and Mount Sinai to help define standards of care. Red Cell Partners announced $3 million in pre-seed funding to fuel the company’s mission and product development.

Led · Equity · Feb 2023

Fortem Technologies, founded in 2016, designs radar-based sensors, command-and-control software and interceptor systems that incorporate artificial intelligence to detect and avoid other aircraft and airborne objects. Its products target defense and commercial customers seeking counter-UAS capabilities. The company has a network of investors including Lockheed Martin, AE Industrial Partners, DCVC, Toshiba, AIM13 and Signia Venture Partners. Recent financing includes a $25 million tranche led by Lockheed as part of a Series B, following prior participation by Lockheed in a $17.8 million round in 2023. Fortem plans to use the new capital to accelerate production at scale and integrate its systems within Lockheed’s Sanctum ecosystem to improve interoperability. The company emphasizes autonomous, integrated, deployable counter-UAS solutions to address rapidly scaling drone threats.